Larvol Delta - Assessment-of-Immunogenicity-Safety-and-Reactogenicity-of-a-Booster-Dose-of-Various-COVID19-Vaccine-Platforms-in-Individuals-Primed-With-Several-Regimes

SCB-2019 - Sichuan Clover Biopharma

http://clinicaltrials.gov/ct2/show/NCT05812586

Apr 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next